Shares in New York-based stem cell specialist BrainStorm Cell Therapeutics have fallen around half ahead of the opening bell, after the firm provided a negative 28 September 2023
Ahead of a panel meeting of the US Food and Drug Administration’s scientists, the agency’s briefing notes paint a pessimistic picture for the amyotrophic latera 26 September 2023
Two Chinese contract development and manufacturing organizations (CDMO) with significant US operations have agreed to collaborate in the growth area of mRNA man 25 September 2023
UK-based Oxford Biomedica, a contract development and manufacturing organization (CDMO), is in talks to buy ABL Europe from family-owned French holding company 21 September 2023
AlveoGene, a UK-based company focused on transforming rare respiratory disease outcomes using inhaled gene therapy has announced its launch. 14 September 2023
Stock in New Jersey, USA-based Rocket Pharmaceuticals shot up around 40% on Wednesday, following good news on the financing and regulatory fronts. 14 September 2023
Swiss pharma giant Novartis has discontinued development of GT005 in geographic atrophy (GA) secondary to dry-age-related macular degeneration (dry-AMD). 12 September 2023
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.